当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析

海森药业

(001367)

  

流通市值:10.34亿  总市值:40.59亿
流通股本:3870.89万   总股本:1.52亿

海森药业(001367)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.61亿元,每股收益0.41元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益139838.50万元,未分配利润49455.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产152474.13万元,负债12635.63万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入242,085,860.34118,478,458.16471,510,162.35320,044,589.93
营业总成本172,703,186.583,568,452.19333,026,439.58220,992,411.05
其他经营收益
营业利润70,225,757.3235,812,754.05142,045,910.94101,629,819.97
利润总额70,493,996.6236,188,906.99141,785,438.94100,257,493.83
净利润60,794,153.3131,212,181.59122,557,731.6586,950,138.58
每股收益
其他综合收益----
综合收益总额60,794,153.3131,212,181.59122,557,731.6586,950,138.58
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,189,498,038.11,243,053,811.771,257,624,341.821,199,091,801.92
非流动资产:
非流动资产合计335,243,247.94262,880,282.35228,367,402.78200,348,612.92
资产总计1,524,741,286.041,505,934,094.121,485,991,744.61,399,440,414.84
流动负债:
流动负债合计108,611,008.41106,716,589122,040,00373,551,569.15
非流动负债:
非流动负债合计17,745,291.8318,673,323.319,797,084.422,922,312.56
负债合计126,356,300.24125,389,912.3141,837,087.496,473,881.71
所有者权益(或股东权益):
归属于母公司股东权益合计1,398,384,985.81,380,544,181.821,344,154,657.21,302,966,533.13
股东权益合计1,398,384,985.81,380,544,181.821,344,154,657.21,302,966,533.13
负债和股东权益合计1,524,741,286.041,505,934,094.121,485,991,744.61,399,440,414.84
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计210,248,668.67104,381,799.72386,608,648.58289,109,710.07
经营活动现金流出小计135,922,035.0963,923,012.35219,452,372.68168,539,885.06
经营活动产生的现金流量净额74,326,633.5840,458,787.37167,156,275.9120,569,825.01
投资活动产生的现金流量:
投资活动现金流入小计338,568,726.3665,213,663.34373,000,531.530,174,271.23
投资活动现金流出小计950,116,302.59281,911,894.16434,748,175.31332,172,088
投资活动产生的现金流量净额-611,547,576.23-216,698,230.82-61,747,643.81-301,997,816.77
筹资活动产生的现金流量:
筹资活动现金流入小计--25,464,450-
筹资活动现金流出小计17,451,010-35,855,62533,407,191.46
筹资活动产生的现金流量净额-17,451,010--10,391,175-33,407,191.46
汇率变动对现金及现金等价物的影响1,166,299.42837,720.092,676,176.571,732,644.01
现金及现金等价物净增加额-553,505,653.23-175,401,723.3697,693,633.66-213,102,539.21
期末现金及现金等价物余额480,976,459.05859,080,388.921,034,482,112.28723,685,939.41
补充资料:
TOP↑